Schedule 13G ownership disclosure

Tenax Therapeutics, Inc.

Security class unavailable · CUSIP: 88032L605

Event date: 2024-08-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
372,797
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-24-000530
Form type
SC 13G
Filer
Stonepine Capital Management, LLC
CIK
CIK 1440771
Filed
Aug 15, 2024
Reporting period
Aug 06, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub